Skip to content
Methodology
All entries for: ArKri Therapeutics
October 22, 2025
ArKri Therapeutics
Orphan Drug Designation
FDA orphan drug designation: treatment of Huntington’s disease
Disease Area:
Rare Diseases
Source
Scroll to Top
